Randomized, Pragmatic Trial Testing Antimicrobial Therapy for Treatment of Idiopathic Pulmonary Fibrosis Shows No Significant Effect
A large pragmatic study in idiopathic pulmonary fibrosis (IPF) found that antimicrobial therapy did not have a statistically significant effect on respiratory hospitalization or death compared with usual care alone.
What ADAPTABLE Has Taught Us
Following the presentation of results from DCRI’s ADAPTABLE
ACC 2021: CONNECT-HF Provides New Data on Heart Failure Quality Improvement
The late-breaking clinical trial found no difference between the intervention group and the control group when examining an audit and feedback initiative that was hypothesized to improve heart failure care.
ACC 2021: ACTION Trial Shows Oral Anticoagulation with Rivaroxaban Does Not Help Patients With COVID-19
The investigators found no significant benefit to patient outcomes when examining time to death, duration of hospitalization, or duration of supplemental oxygen.
ACC 2021: ADAPTABLE Answers the Aspirin Question, Provides Framework for Novel Research Methods
The results provide insight into which dose may be best for most patients.
DCRI to Help Understand How Existing Drugs can Improve Symptoms and Clinical Outcomes for People with COVID-19
The DCRI has received $44 million in funding to examine whether three immune modulators help prevent overactive immune response in moderate or severe cases of COVID-19.
ABC Science Collaborative to Lead New Study on COVID-19 Testing in Schools
The study includes both surveillance and exposure testing to reduce COVID-19 transmission and interviews with families to increase trust within communities.
DCRI Strength in Building Networks Highlighted by Antibacterial Resistance Leadership Group Achievements
The Antibacterial Resistance Leadership Group (ARLG) involves over 100 experts, generating over 155 papers and initiating 55+ studies with 21,000 participants at 130 sites in 12 countries.
Study Shows Importance of Patient-Reported Outcomes in Heart Failure Care
More than twice as many patients saw changes in their patient-reported outcome measures compared with their traditional NYHA measures used by clinicians.
DCRI to Co-Lead Program for Self-Administered COVID-19 Testing
The program will evaluate testing results and other data to determine whether the intervention of providing self-administered COVID-19 tests helps to slow the rate of community transmission.